| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 56.982 | 82.277 | 92.000 | 103.675 | 112.391 | 146.599 | 198.289 |
| Total Income - EUR | - | - | - | 57.950 | 82.847 | 92.001 | 105.698 | 112.392 | 155.982 | 235.323 |
| Total Expenses - EUR | - | - | - | 15.412 | 41.166 | 30.077 | 27.887 | 25.587 | 54.567 | 104.481 |
| Gross Profit/Loss - EUR | - | - | - | 42.537 | 41.680 | 61.924 | 77.811 | 86.805 | 101.415 | 130.842 |
| Net Profit/Loss - EUR | - | - | - | 42.011 | 40.897 | 61.073 | 76.987 | 85.763 | 100.255 | 125.786 |
| Employees | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Danaderm Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 10.616 | 10.146 | 6.990 | 3.326 | 223.461 | 193.877 |
| Current Assets | - | - | - | 43.194 | 55.188 | 86.748 | 91.348 | 114.353 | 114.783 | 152.953 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 6.404 | 34.781 | 60.939 | 58.773 | 74.387 | 108.378 | 137.121 |
| Cash | - | - | - | 36.790 | 20.407 | 25.809 | 32.575 | 39.966 | 6.404 | 15.832 |
| Shareholders Funds | - | - | - | 7.671 | 41.413 | 64.281 | 80.277 | 107.367 | 108.892 | 167.257 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 35.523 | 24.391 | 32.613 | 18.061 | 10.312 | 229.352 | 24.978 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 154.595 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Danaderm Medical Srl